NLRP3 and hyperuricemia: In summary, the CE inhibits XOD and reduces uric acid production, enhances uric acid excretion, improves kidney tissue oxidative stress levels, regulates the expression of NLRP3-Inflamase-related pathway proteins, and alleviates hyperuricemia induced by a high-purine yeast diet and uric acid nephropathy.